Canada markets closed

Carl Zeiss Meditec AG (AFX.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
117.80-1.55 (-1.30%)
At close: 01:40PM CET

Carl Zeiss Meditec AG

Goschwitzer Strasse 51-52
Jena 07745
Germany
49 3641 220 115
https://www.zeiss.com/meditec-ag/de/investor-relations.html?vaURL=www.zeiss.de/meditec-ag/ir

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full Time Employees4,823

Key Executives

NameTitlePayExercisedYear Born
Dr. Markus WeberCEO & Chairman of Management Board905.4kN/AN/A
Mr. Justus Felix WehmerCFO & Member of the Management Board609.4kN/A1965
Dr. Christian MunsterHead of Global Regulatory & Clinical Affairs, CoCe Site Jena & Emp. Rep. Member of Supervisory BoardN/AN/A1971
Stefanie SpanagelChief Operating OfficerN/AN/AN/A
Mr. Sebastian FrericksDirector of Investor RelationsN/AN/AN/A
Eva-Maria HeineChief Human Resources OfficerN/AN/AN/A
Mr. Steven C. Schallhorn M.D.Chief Medical Officer for Global Ophthalmic DevicesN/AN/AN/A
Mr. Andrew ChangHead of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec, Inc.N/AN/AN/A
Dr. Euan S. Thomson Ph.D.President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business UnitN/AN/A1963
Mr. Magnus ReibenspiessHead of the Microsurgery Strategic Business Unit - ZEISS Medical TechnologyN/AN/AN/A
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Corporate Governance

Carl Zeiss Meditec AG’s ISS Governance QualityScore as of March 1, 2024 is 8. The pillar scores are Audit: 4; Board: 7; Shareholder Rights: 6; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.